Evidence map›Paper›PMID 33806830›Full record

ArticleMarine drugs2021

Antiproliferative Properties of Scandium Exopolysaccharide Complexes on Several Cancer Cell Lines.

Javier Muñoz-Garcia, Mattia Mazza, Cyrille Alliot, Corinne Sinquin, Sylvia Colliec-Jouault, Dominique Heymann, Sandrine Huclier-Markai

Open access · goldAbstract readComparative Study
In one paragraph

Article in Marine drugs, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
1.0field-weighted citation impact, top 29% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 12 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Review
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 4 institutions in 2 countries.

Javier Muñoz-GarciaInstitut de Cancérologie de l'Ouest, Université de Nantes, Blvd Jacques Monod, F-44805 Saint-Herblain, France.
Mattia MazzaGIP ARRONAX, 1 rue Aronnax, CEDEX 3, F-44817 Nantes, France.
Cyrille AlliotGIP ARRONAX, 1 rue Aronnax, CEDEX 3, F-44817 Nantes, France.
Corinne SinquinIFREMER, Institut Français de Recherche pour L'exploitation de la mer, rue de l'Ile d'Yeu, BP21105, CEDEX 3, F-44311 Nantes, France.ORCID 0000-0002-8930-9535
Sylvia Colliec-JouaultIFREMER, Institut Français de Recherche pour L'exploitation de la mer, rue de l'Ile d'Yeu, BP21105, CEDEX 3, F-44311 Nantes, France.ORCID 0000-0002-2449-5410
Dominique HeymannInstitut de Cancérologie de l'Ouest, Université de Nantes, Blvd Jacques Monod, F-44805 Saint-Herblain, France.ORCID 0000-0001-7777-0669
Sandrine Huclier-MarkaiGIP ARRONAX, 1 rue Aronnax, CEDEX 3, F-44817 Nantes, France.ORCID 0000-0003-1948-6701
Ifremer · FRInstitut de Cancérologie de l'Ouest · FRMontpellier GenomiX · FRInserm · FR

Funding

Agence Nationale de la Recherche ANR-11-EQPX-0004Agence Nationale de la Recherche ANR-11-LABX-0018-01Agence Nationale de la Recherche ANR-16-IDEX-0007
6 · The paper itself

Abstract

Antimetastatic properties on both murine and human osteosarcoma cell lines (POS-1 and KHOS) have been evidenced using exopolysaccharide (EPS) derivatives, produced by

Indexed as

A549 CellsAlteromonasAnimalsCaco-2 CellsCell ProliferationCoordination ComplexesHeparinHumansKineticsMiceNeoplasmsPolysaccharides, BacterialScandiumCoordination ComplexesHeparinPolysaccharides, BacterialScandiumcancer cell linesexopolysaccharidesproliferationscandiumtheranostic

Identifiers

PMID33806830
PMCPMC8005100
OpenAlexW3139507410

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.